MITOTECH

mitotech-logo

Mitotech S.A. is a Luxembourg-based single-molecule biotechnology company with a portfolio of novel drugs for the treatment of age-related disorders undergoing early, middle and late stages of drug development. Their drug portfolio consists of an ophthalmic drug (Visomitin™) and a systemic drug (Plastomitin™) that both have their lead compound SkQ1 – a highly efficient mitochondria-targeted antioxidant – as their active ingredient. Their core team is a unique fusion of cross-disciplinar... y scientific experts, seasoned clinical drug development professionals and experienced business managers. Using this blend of business skills, industry expertise and fundamental scientific knowledge their company aims to approach complex scientific problems, such as protection against cellular oxidative stress, and turn the results of biological research into a line-up of pharmaceutical products. Company’s mission is to leverage the break-through in delivering highly active antioxidants into mitochondria across a wide spectrum of age-related therapeutic indications and to deliver medications with this novel mechanism of action to millions of patients worldwide.

#SimilarOrganizations #People #Website #More

MITOTECH

Social Links:

Industry:
Biotechnology Health Care

Founded:
2009-01-01

Address:
Luxembourg, Luxembourg, Luxembourg

Country:
Luxembourg

Website Url:
http://www.mitotechpharma.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Microsoft Microsoft Azure Microsoft Azure US Central Region


Similar Organizations

clanotech-ab-logo

Clanotech AB

Clanotech AB is active in ophthalmology

curotech-labs-logo

Curotech Labs

Curotech Labs is a biotechnology based company.

lino-bioteh-logo

lino Bioteh

lino Biotech is a biotechnology company.

london-biotech-logo

London biotech

London biotech is a world-class R&D based company.

themis-bioscience-logo

Themis Bioscience

Themis Bioscience is a start-up biotechnology company.

Current Employees Featured

not_available_image

John M. Barberich
John M. Barberich CFO @ Mitotech
CFO

maxim-skulachev_image

Maxim Skulachev
Maxim Skulachev CEO @ Mitotech
CEO
2010-10-01

natalia-perekhvatova_image

Natalia Perekhvatova
Natalia Perekhvatova CEO @ Mitotech
CEO
2010-07-01

not_available_image

Anton Petrov
Anton Petrov COO @ Mitotech
COO
2010-09-01

not_available_image

Lawrence Friedhoff
Lawrence Friedhoff CCO @ Mitotech
CCO

Official Site Inspections

http://www.mitotechpharma.com Semrush global rank: 5.75 M Semrush visits lastest month: 1.45 K

  • Host name: static.210.123.78.5.clients.your-server.de
  • IP address: 5.78.123.210
  • Location: Tehran Iran
  • Latitude: 35.727
  • Longitude: 51.3336
  • Timezone: Asia/Tehran

Loading ...

More informations about "Mitotech"

Welcome | Mitotech

Sep 17, 2024 · By developing small molecules aimed at mitigating these processes, Mitotech is working in an exciting and essential area of drug development.See details»

About Us | Mitotech - mitotechpharma.com

Mitotech is a pioneering biotechnology company at the cutting edge of mitochondrial medicine, leading efforts to develop innovative therapies for a range of serious and complex health …See details»

Management Team | Mitotech - mitotechpharma.com

See details»

Mitotech - Crunchbase Company Profile & Funding

Mitotech S.A. is a Luxembourg-based single-molecule biotechnology company with a portfolio of novel drugs for the treatment of age-related disorders undergoing early, middle and late …See details»

Mitotech - mitoworld.org

Mitotech is a biotechnology company with a portfolio of novel mitochondria-targeted small molecules. Dysfunctional mitochondria are implicated in aging and many neurodegenerative, …See details»

Mitotech S.A. | LinkedIn

A European biotechnology company, developing novel mitochondria-targeted drugs for treatment of neurodegenerative and metabolic diseases. The company's goal is to develop and market a …See details»

Mitotech Pharma - VentureRadar

We are an innovative biopharmaceutical company developing therapies to treat the mitochondrial dysfunction associated with genetic mitochondrial diseases and many common age-related …See details»

Mitotech - Overview, News & Similar companies | ZoomInfo.com

Oct 13, 2022 · Mitotech contact info: Phone number: +352 271127060 Website: www.mitotechpharma.com What does Mitotech do? Mitotech S.A. is a Luxembourg-based …See details»

Mitotech granted Orphan Drug Designation by FDA for …

Dec 15, 2021 · Mitotech Ltd, a UK-based clinical-stage biotechnology company in ophthalmology, announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug …See details»

Mitotech Company Profile - Craft

Mitotech is a company that develops pharmaceutical products based on mitochondria-targeted antioxidants. It specializes in drug candidates used for the treatment of age-related disorders. …See details»

Mitotech Granted Orphan Drug Designation by FDA for Visomitin …

Dec 16, 2021 · Mitotech S.A. is a Luxembourg-based late clinical stage biotechnology company developing drugs to treat the mitochondrial oxidative stress underlying predominantly age …See details»

Mitotech CSO to Present Visomitin® Data in Dry Eye Disease

Feb 24, 2022 · Mitotech S.A. is a Luxembourg-based late clinical stage biotechnology company developing drugs to treat the mitochondrial oxidative stress underlying predominantly age …See details»

About - Mitotech

Mitotech is working to do everything reasonably possible to minimize disruption to patients participating in its clinical trials and to meet their needs during this uncertain time. This page is …See details»

Mitotech Granted Orphan Drug Designation by FDA for

Dec 16, 2021 · Mitotech S.A. is a Luxembourg-based late clinical stage biotechnology company developing drugs to treat the mitochondrial oxidative stress underlying predominantly age …See details»

MITOTECH presents promising results in friedreich’s ataxia

Sep 17, 2024 · Mitotech Ltd, a mitochondria-focused clinical-stage biotechnology company, presented new data for its mitochondria-targeted ferroptosis inhibitor in Friedreich’s Ataxia …See details»

Mitotech CSO to Present Visomitin® Data in Dry Eye Disease

Feb 24, 2022 · For more information, please visit www.mitotechpharma.com. Visomitin is a cardiolipin peroxidation inhibitor, under development for multiple indications including LHON, …See details»

News - Mitotech

Jan 26, 2022 · November 15, 2024. Mitotech Presents New positive Animal Efficacy Data for SkQ1 in MASH Treatment at The 75th Liver Meeting. November 6, 2024. Mitotech Unveils …See details»

Mitotech to Host Key Opinion Leader Webinar on Visomitin®: A …

Jan 26, 2022 · Mitotech Ltd is a UK-based late clinical stage biotechnology company developing drugs to treat the mitochondrial oxidative stress underlying predominantly age-related …See details»

linkstock.net © 2022. All rights reserved